Figure 1From: Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialStudy design. Different weeks (W) of the study are described. Screening, HLA typing and tumor evaluation were performed within 2 weeks before lymphapheresis. DTH (Multi MĂ©rieux skin test) was performed at the time of lymphapheresis, and exosome vaccine started 3 weeks later.Back to article page